SNPHY

SANTEN PHARMACEUTICAL UN ADR

SNPHY·80287P100·US·ADR·Healthcare - Drug Manufacturers - General

SNPHY (SANTEN PHARMACEUTICAL UN ADR) is held by 1 institutional investors as of Q1 2026. Largest holders: RHUMBLINE ADVISERS ($333).

1
Holders
Avg rating(1 Elite)
$333
Total Value
0% (1)
Fund Consensus

No verdict yet — fewer than 2 funds hold SNPHY.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used